Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus clausii as adjunct therapy in children with rotavirus diarrhea
PACTR202502827841363Completed
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- Aug 2023
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label trial of bacillus clausii in rotaviral diarrhea (2 arms), sponsored by Faculty of Medicine, Tanta University. Primary endpoints: Response to treatment, Diarrhea severity and 1 more. Started Aug 2023; status: completed.
02
Drugs
bacillus clausii
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on PACTR202502827841363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502827841363.